Due to the special nature of medicines, returns and exchanges are not supported.
Final delivery from the nearest overseas warehous NEW

圣利卓/Spevigo

Boehringer Ingelheim International GmbH has applied for the marketing of Pesorizumab Injection (trade name: Spevigo) for the treatment of acute attacks of generalized pustular psoriasis (GPP) in adults.

Share:

Featured products

Laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor.